Phage display of intact domains at high copy number: a system based on SOC, the small outer capsid protein of bacteriophage T4
- PMID: 8880907
- PMCID: PMC2143533
- DOI: 10.1002/pro.5560050909
Phage display of intact domains at high copy number: a system based on SOC, the small outer capsid protein of bacteriophage T4
Abstract
Peptides fused to the coat proteins of filamentous phages have found widespread applications in antigen display, the construction of antibody libraries, and biopanning. However, such systems are limited in terms of the size and number of the peptides that may be incorporated without compromising the fusion proteins' capacity to self-assemble. We describe here a system in which the molecules to be displayed are bound to pre-assembled polymers. The polymers are T4 capsids and polyheads (tubular capsid variants) and the display molecules are derivatives of the dispensable capsid protein SOC. In one implementation, SOC and its fusion derivatives are expressed at high levels in Escherichia coli, purified in high yield, and then bound in vitro to separately isolated polyheads. In the other, a positive selection vector forces integration of the modified soc gene into a soc-deleted T4 genome, leading to in vivo binding of the display protein to progeny virions. The system is demonstrated as applied to C-terminal fusions to SOC of (1) a tetrapeptide; (2) the 43-residue V3 loop domain of gp120, the human immunodeficiency virus type-1 (HIV-1) envelope glycoprotein; and (3) poliovirus VP1 capsid protein (312 residues). SOC-V3 displaying phage were highly antigenic in mice and produced antibodies reactive with native gp120. That the fusion protein binds correctly to the surface lattice was attested in averaged electron micrographs of polyheads. The SOC display system is capable of presenting up to approximately 10(3) copies per capsid and > 10(4) copies per polyhead of V3-sized domains. Phage displaying SOC-VP1 were isolated from a 1:10(6) mixture by two cycles of a simple biopanning procedure, indicating that proteins of at least 35 kDa may be accommodated.
Similar articles
-
Bacteriophage T4 nanoparticle capsid surface SOC and HOC bipartite display with enhanced classical swine fever virus immunogenicity: a powerful immunological approach.J Virol Methods. 2007 Jan;139(1):50-60. doi: 10.1016/j.jviromet.2006.09.017. Epub 2006 Nov 1. J Virol Methods. 2007. PMID: 17081627
-
A bipartite bacteriophage T4 SOC and HOC randomized peptide display library: detection and analysis of phage T4 terminase (gp17) and late sigma factor (gp55) interaction.J Mol Biol. 2002 May 31;319(2):289-304. doi: 10.1016/S0022-2836(02)00298-X. J Mol Biol. 2002. PMID: 12051907
-
Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.Vaccine. 2008 Mar 10;26(11):1471-81. doi: 10.1016/j.vaccine.2007.12.053. Epub 2008 Jan 24. Vaccine. 2008. PMID: 18289743
-
T4 bacteriophage as a phage display platform.Arch Microbiol. 2014 Jul;196(7):473-9. doi: 10.1007/s00203-014-0989-8. Epub 2014 May 15. Arch Microbiol. 2014. PMID: 24828789 Free PMC article. Review.
-
Hybrid Rop-pIII proteins for the display of constrained peptides on filamentous phage capsids.Ann Biol Clin (Paris). 1993;51(10-11):917-22. Ann Biol Clin (Paris). 1993. PMID: 8210070 Review.
Cited by
-
Molecular imaging of T4 phage in mammalian tissues and cells.Bacteriophage. 2014 Jan 1;4(1):e28364. doi: 10.4161/bact.28364. Epub 2014 Feb 27. Bacteriophage. 2014. PMID: 24653943 Free PMC article.
-
Phage based vaccine: A novel strategy in prevention and treatment.Heliyon. 2023 Sep 15;9(9):e19925. doi: 10.1016/j.heliyon.2023.e19925. eCollection 2023 Sep. Heliyon. 2023. PMID: 37809683 Free PMC article. Review.
-
The collagen-like protein gp12 is a temperature-dependent reversible binder of SPP1 viral capsids.J Biol Chem. 2014 Sep 26;289(39):27169-27181. doi: 10.1074/jbc.M114.590877. Epub 2014 Jul 29. J Biol Chem. 2014. PMID: 25074929 Free PMC article.
-
T4 Phage Displaying Dual Antigen Clusters Against H3N2 Influenza Virus Infection.Vaccines (Basel). 2025 Jan 13;13(1):70. doi: 10.3390/vaccines13010070. Vaccines (Basel). 2025. PMID: 39852849 Free PMC article.
-
Preparation and Evaluation of the Fully Humanized Monoclonal Antibody GD-mAb Against Respiratory Syncytial Virus.Front Cell Infect Microbiol. 2019 Jul 31;9:275. doi: 10.3389/fcimb.2019.00275. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31417879 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources